ISO 10993-18 is a critical standard for evaluating the biological safety of medical devices through chemical characterization. This standard defines methods for identifying and quantifying chemical substances that may be present in medical devices and could impact patient safety. Understanding and implementing ISO 10993-18 is essential for manufacturers seeking regulatory compliance and ensuring product safety.
We have been extensively discussing about biocompatibility related issue, such as Biological risk assessment, ISO 10993-6 , ISO 10993-7, and much more.
Importance of ISO 10993-18 in Medical Device Safety
ISO 10993-18 provides a framework for assessing the chemical composition of medical devices. This process supports multiple applications, including:
- Ensuring compliance with ISO 10993-1 and ISO 14971 for biological risk assessment.
- Evaluating the safety of reprocessed medical devices.
- Determining the potential for leachable substances under clinical use, essential for ISO 10993-17 toxicological risk assessment.
- Demonstrating equivalence to established medical devices through extractables and leachables analysis.
- Assessing the impact of manufacturing changes, including sterilization, material sourcing, and site transfers.
- Comparing new materials against clinically established materials based on composition and extractable profiles.
- Validating prototype medical devices against final versions based on chemical characterization data.
- Screening potential new materials to confirm their chemical suitability for clinical applications.
While ISO 10993-18 chemical characterization is a critical component of medical device evaluation, it does not replace biological testing. Instead, it complements risk assessment and can sometimes reduce the need for certain biological tests.
Medical Device Configuration and Material Composition in ISO 10993-18
A medical device’s configuration and material composition determine its potential chemical interactions with the body. If a device does not have direct or indirect body contact, ISO 10993-18 chemical characterization is unnecessary.
The hypothetical worst-case chemical release is established by analyzing the configuration and composition of the device. This requires collecting detailed information on:
- The materials of construction, including their proportions within the device.
- The physical structure, including surface topography and chemistry.
- The geometric distribution of materials, defining points of patient contact.
Once the device configuration is documented, each material in direct or indirect contact must be described. A qualitative and quantitative analysis of composition, including potential additives and processing residues, is essential. The level of detail required depends on the device’s risk profile, with long-term and implantable devices needing a higher level of scrutiny.
Information Collection and Chemical Testing in ISO 10993-18
Manufacturers should gather qualitative and quantitative data from material suppliers, including:
- Processing additives such as mold release agents.
- Extractables and leachables information.
- Toxicological risk assessment data.
If supplier data is insufficient, additional chemical testing may be required. This includes compositional, extractables, and leachables testing to fill data gaps and ensure compliance.
When toxicological hazards are identified, missing data must be supplemented through literature reviews, laboratory testing, or alternative methods. The extent of required testing depends on factors such as existing knowledge of material formulation, prior safety data, and device contact duration.
Material and Chemical Equivalence
The ISO 10993-18 standard requires demonstrating equivalence between a new medical device and a clinically established device. Equivalence assessments consider:
- Configuration and composition.
- Manufacturing and processing methods.
- Intended use and clinical exposure.
Material equivalence can be based on composition, impurities, or extractable profiles, provided that analytical methods are well-documented and justified. If equivalence is confirmed, chemical characterization is complete. Otherwise, further ISO 10993-1 biological evaluations may be necessary.
Hypothetical Worst-Case Chemical Release Assessment
A worst-case chemical release scenario assumes that all device components transfer their chemical content to the patient. This extreme scenario helps establish safety thresholds and assess potential health risks.
Key considerations include:
- The likelihood of a device dissolving completely in the body.
- The potential for all chemical constituents to leach out during use.
- The total exposure of the patient to these chemicals.
The qualitative and quantitative data from ISO 10993-18 chemical characterization is used to determine whether exposure meets safety thresholds. If exposure is deemed acceptable, the process is complete. If not, further testing or toxicological risk assessment is required.
Analytical Evaluation Threshold (AET)
The Analytical Evaluation Threshold (AET) in ISO 10993-18 is used to determine whether a detected substance requires toxicological assessment. The AET should ideally be derived from a safety-based threshold, such as the Toxicological Threshold of Concern (TTC).
If a safety-based threshold is not practical, an analytical threshold (e.g., Limit of Quantification (LOQ)) can be used. However, differences between the AET and LOQ must be justified within the toxicological risk assessment process.
Reporting Requirements Under ISO 10993-18
A chemical assessment report is mandatory for documenting ISO 10993-18 compliance and supporting toxicological risk assessment. This report should include:
- A description of the test article (material or medical device) and sample preparation details.
- Analytical methods and extraction conditions used.
- System suitability testing documentation and results.
- Justification of the Analytical Evaluation Threshold (AET).
- Qualitative data, including extractables identification methods.
- Quantitative data, detailing extractable concentrations and classification.
- Estimated clinical exposure to chemicals (e.g., analyte amounts in μg/device).
Substances may be grouped based on chemical structure or functional similarities to aid in toxicological evaluations. Additionally, reports should include vendor-supplied data and relevant literature references when applicable. Proper documentation ensures transparency in the ISO 10993-18 chemical characterization process.
Connection Between ISO 10993-18 and ISO 14971
ISO 14971 is the international standard for the application of risk management to medical devices. It provides a systematic process for identifying, evaluating, controlling, and monitoring risks associated with medical devices. ISO 10993-18 plays a crucial role in this risk management framework by supplying essential chemical characterization data that informs risk assessments under ISO 14971.
The key connections between ISO 10993-18 and ISO 14971 include:
- Hazard Identification: ISO 10993-18 helps identify potential chemical hazards by determining the presence of extractables and leachables that could pose risks to patients.
- Risk Analysis: The data from ISO 10993-18 supports toxicological risk assessment, which is a fundamental part of ISO 14971.
- Risk Evaluation: The chemical characterization results provide necessary input to determine whether a device meets acceptable safety thresholds under ISO 14971.
- Risk Control Measures: If chemical characterization identifies hazardous substances, manufacturers can implement risk control strategies such as material modifications, process changes, or additional testing to mitigate risks.
- Ongoing Risk Monitoring: ISO 14971 requires continuous post-market surveillance. Chemical characterization data from ISO 10993-18 can be used in periodic safety reviews to ensure continued compliance and device safety.
By integrating ISO 10993-18 with ISO 14971, manufacturers can effectively manage risks related to chemical exposure and ensure compliance with global regulatory requirements.
Conclusion
ISO 10993-18 is a fundamental standard for medical device chemical characterization. It ensures that devices meet safety and regulatory requirements by integrating chemical analysis with risk assessment. A structured approach to ISO 10993-18 compliance enhances product safety while minimizing unnecessary biological testing.
By following ISO 10993-18, manufacturers can:
- Ensure device materials meet safety standards.
- Demonstrate equivalence to established medical devices.
- Minimize regulatory risks and streamline approval processes.
- Conduct cost-effective testing while ensuring patient safety.
For any company involved in medical device manufacturing, understanding and implementing ISO 10993-18 is essential for achieving regulatory success and maintaining high product safety standards.
Subscribe to 4EasyReg Newsletter
4EasyReg is an online platform dedicated to Regulatory matters within the medical device, information security and AI-Based business.
We offer a wide range of documentation kits to support your compliance efforts towards a wide range of standards and regulations, such as ISO 13485, EU MDR, ISO 27001, ISO 42001 and much more. . Specifically, in our webshop you will find:
- ISO 13485 Documentation / Compliance Kit
- EU MDR Documentation Kit
- MDSAP Documentation Kit
- ISO 27001 Documentation / Compliance Kit
- ISO 42001 Documentation / Compliance Kit
- FDA Cybersecurity Documentation
Within our sister platform QualityMedDev Academy, a wide range of online & self-paced training courses is available, such as for example:
- Complaint Handling and Vigilance Reporting
- Artificial Intelligence in Medical Device. Regulatory Requirements
- Unique Device Identification (UDI) Requirements according to EU MDR
- Clinical Evaluation Process According to EU MDR
- Medical Device SW Verification & Validation
- Risk Management for Medical Devices
- Usability Evaluation for Medical Devices
As one of the leading online platforms in the medical device sector, 4EasyReg offers extensive support for regulatory compliance. Our services cover a wide range of topics, from EU MDR & IVDR to ISO 13485, encompassing risk management, biocompatibility, usability, software verification and validation, and assistance in preparing technical documentation for MDR compliance.
Do not hesitate to subscribe to our Newsletter!
